搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
11 小时
on MSN
China Has Detained a Senior AstraZeneca Executive
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...
1 天
on MSN
AstraZeneca's China chief in custody, believes unrelated to insurance probe
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...
2 天
on MSN
AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...
Investopedia on MSN
1 天
AstraZeneca Shares Slide As Execs in China Face Fraud Investigation
AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...
美国之音
6 小时
阿斯利康中国区负责人被拘留,公司认为与保险调查无关
阿斯利康(AstraZeneca)公司周三 (11月6日)表示,其中国区总裁王磊已被中国当局拘留。尽管公司并不知道原因,但认为这与涉及公司的大型医疗保险欺诈案无关。 阿斯利康称,其首席财务官阿拉德娜·萨林 (Aradhana ...
STAT
19 小时
AstraZeneca says China has detained a senior executive
The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...
2 小时
New AstraZeneca facility in Tuas South to create over 800 jobs, ready by 2029
SINGAPORE – Pharmaceutical giant AstraZeneca is set to create over 800 skilled jobs here to staff a new manufacturing facility in Tuas South. The jobs range from those in engineering and technical ...
1 天
AstraZeneca Says Current, Former Executives Involved in China Probe
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...
2 天
AstraZeneca Falls Most Since 2020 as China Probe Fears Mount
AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...
腾讯网
2 天
超18亿美元合作核心,阿斯利康口服GLP-1疗法4周减重5.8%
▎药明康德内容团队编辑今日,阿斯利康(AstraZeneca)公司公布了在研口服GLP-1疗法AZD5004,在患有2型糖尿病的肥胖患者中进行的1期临床试验的最新结果。数据显示,这款在研疗法在治疗4周后将患者体重减轻5.8%,并且改善患者的血糖指标。
Wall Street Journal
3 天
AstraZeneca Says Obesity Pill Shows Minimal Side Effects in Early Trial
AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The Anglo ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈